93.64
price down icon1.24%   -1.18
after-market アフターアワーズ: 93.64
loading
前日終値:
$94.82
開ける:
$94.43
24時間の取引高:
3.66M
Relative Volume:
0.72
時価総額:
$53.92B
収益:
$6.30B
当期純損益:
$1.07B
株価収益率:
50.87
EPS:
1.8406
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
+1.79%
1か月 パフォーマンス:
+9.07%
6か月 パフォーマンス:
+10.71%
1年 パフォーマンス:
+22.58%
1日の値動き範囲:
Value
$92.89
$95.13
1週間の範囲:
Value
$91.82
$96.29
52週間の値動き範囲:
Value
$72.30
$96.29

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1094)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
16,000
Name
Twitter
@edwardslifesci
Name
次回の収益日
2026-07-23
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

Compare EW vs ABT, SYK, MDT, BSX

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
EW icon
EW
Edwards Lifesciences Corp
93.64 54.60B 6.30B 1.07B 1.09B 1.8406
ABT icon
ABT
Abbott Laboratories
95.18 166.94B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
326.85 126.41B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
82.01 107.31B 36.36B 4.84B 5.43B 3.7212
BSX icon
BSX
Boston Scientific Corp
44.81 67.33B 20.62B 3.56B 3.48B 2.3847

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-01 アップグレード Wolfe Research Peer Perform → Outperform
2026-01-09 アップグレード TD Cowen Hold → Buy
2025-12-18 アップグレード JP Morgan Neutral → Overweight
2025-11-03 アップグレード Raymond James Mkt Perform → Outperform
2025-10-29 アップグレード Jefferies Hold → Buy
2025-10-29 アップグレード Wolfe Research Underperform → Peer Perform
2025-10-08 ダウングレード Oppenheimer Outperform → Perform
2025-10-07 アップグレード Evercore ISI In-line → Outperform
2025-07-29 アップグレード BTIG Research Neutral → Buy
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
01:53 AM

Edwards Lifesciences (NYSE:EW) Valve Data Keeps Healthcare Focus - Kalkine Media

01:53 AM
pulisher
09:09 AM

Edwards Lifesciences focuses on heart valve growth as US cardiac demand stays solid - AD HOC NEWS

09:09 AM
pulisher
Jul 07, 2026

The Edwards SAPIEN 3 Ultra ValvePrecision Transcatheter Option For US Heart Patients - AD HOC NEWS

Jul 07, 2026
pulisher
Jul 07, 2026

Form 4 Edwards Lifesciences Corp For: 7 July By Investing.com - Investing.com Nigeria

Jul 07, 2026
pulisher
Jul 07, 2026

Edwards Lifesciences’ SWOT analysis: stock gains momentum on market share opportunity - Investing.com

Jul 07, 2026
pulisher
Jul 07, 2026

Edwards Lifesciences (EW) executive has shares withheld for tax on vesting - Stock Titan

Jul 07, 2026
pulisher
Jul 07, 2026

Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth prosp - AD HOC NEWS

Jul 07, 2026
pulisher
Jul 06, 2026

Edwards Lifesciences Investors Seek 1st OK For $39M Deal - Law360

Jul 06, 2026
pulisher
Jul 06, 2026

EWEdwards Lifesciences Corp Latest SEC Filings - Finviz

Jul 06, 2026
pulisher
Jul 06, 2026

EW Maintained by Evercore ISI Group -- Price Target Raised to $1 - GuruFocus

Jul 06, 2026
pulisher
Jul 06, 2026

Edwards Lifesciences Corp (EW): Analyst Consensus Points to Growth Potential in the Medical Device Sector - DirectorsTalk Interviews

Jul 06, 2026
pulisher
Jul 06, 2026

Edwards Lifesciences stock leans on its core heart valve business - AD HOC NEWS

Jul 06, 2026
pulisher
Jul 03, 2026

Law firm investigates Edwards Lifesciences offi... - Pluang

Jul 03, 2026
pulisher
Jul 03, 2026

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? - marketscreener.com

Jul 03, 2026
pulisher
Jul 02, 2026

EW News | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill

Jul 02, 2026
pulisher
Jul 02, 2026

Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jul 02, 2026
pulisher
Jul 02, 2026

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN

Jul 02, 2026
pulisher
Jul 02, 2026

TD Cowen Names Edwards Lifesciences as Top Medical Device Pick By Investing.com - Investing.com Nigeria

Jul 02, 2026
pulisher
Jul 02, 2026

TD Cowen Names Edwards Lifesciences as Top Medical Device Pick - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Edwards Lifesciences stock hits 52-week high at 92.94 USD By Investing.com - Investing.com Nigeria

Jul 02, 2026
pulisher
Jul 02, 2026

Edwards Lifesciences stock hits 52-week high at 92.94 USD - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Top Edwards Lifesciences (EW) Competitors 2026 - MarketBeat

Jul 02, 2026
pulisher
Jul 01, 2026

What You Need To Know Ahead of Edwards Lifesciences' Earnings Release - Yahoo Finance

Jul 01, 2026
pulisher
Jul 01, 2026

Edwards Lifesciences highlights heart valve portfolio as investors watch long-term growth - AD HOC NEWS

Jul 01, 2026
pulisher
Jun 30, 2026

Insider Sell Alert: Daniel Lippis Sells Shares of Edwards Lifesc - GuruFocus

Jun 30, 2026
pulisher
Jun 30, 2026

Edwards Lifesciences CVP Daniel Lippis sells $56k in stock By Investing.com - Investing.com Nigeria

Jun 30, 2026
pulisher
Jun 30, 2026

Form 4 Edwards Lifesciences Corp For: 30 June By Investing.com - Investing.com Canada

Jun 30, 2026
pulisher
Jun 30, 2026

TAX MANAGED MULTI CAP GROWTH PORTFOLIO's Edwards Lifesciences Corp(EW) Holding History - GuruFocus

Jun 30, 2026
pulisher
Jun 30, 2026

Edwards Lifesciences CVP Daniel Lippis sells $56k in stock - Investing.com

Jun 30, 2026
pulisher
Jun 30, 2026

Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating - marketscreener.com

Jun 30, 2026
pulisher
Jun 30, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 30, 2026
pulisher
Jun 29, 2026

Edwards Lifesciences (EW) Gains FDA Approval for Ecliptis System - GuruFocus

Jun 29, 2026
pulisher
Jun 29, 2026

Edwards Lifesciences Corporation(NYSE: EW) added to Russell Midcap Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Edwards Lifesciences: The Heart of OC Medtech - Orange County Business Journal

Jun 29, 2026
pulisher
Jun 28, 2026

Edwards Lifesciences presents fresh trial data, shares supported by robust S&P 500 positioning - AD HOC NEWS

Jun 28, 2026
pulisher
Jun 27, 2026

Edwards Lifesciences Corporation $EW Shares Sold by OLD National Bancorp IN - MarketBeat

Jun 27, 2026
pulisher
Jun 26, 2026

Edwards Lifesciences Reports New Clinical Trial Updates - Orange County Business Journal

Jun 26, 2026
pulisher
Jun 26, 2026

Edwards Lifesciences presents trial data at New York conference - Investing.com

Jun 26, 2026
pulisher
Jun 26, 2026

Edwards Lifesciences presents trial data at New York conference By Investing.com - Investing.com UK

Jun 26, 2026
pulisher
Jun 26, 2026

Edwards brings fresh valve data to New York, with TAVR study update - Stock Titan

Jun 26, 2026
pulisher
Jun 24, 2026

A Look at Edwards Lifesciences Corp (EW) After 3.1% Gain -- GF V - GuruFocus

Jun 24, 2026
pulisher
Jun 24, 2026

Edwards Lifesciences stock hits 52-week high at 89.7 USD By Investing.com - Investing.com South Africa

Jun 24, 2026
pulisher
Jun 24, 2026

Edwards Lifesciences stock hits 52-week high at 89.7 USD - Investing.com

Jun 24, 2026
pulisher
Jun 23, 2026

Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Jun 23, 2026
pulisher
Jun 23, 2026

Edwards Lifesciences clears fresh Medicare hurdle, shares consolidate after 52-week high - Ad-hoc-news.de

Jun 23, 2026
pulisher
Jun 23, 2026

Edwards Lifesciences Corp (EW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026
pulisher
Jun 23, 2026

SAPIEN 3 Ultra from Edwards Lifesciences Corp.lower-profile TAVI and refined delivery - AD HOC NEWS

Jun 23, 2026
pulisher
Jun 22, 2026

Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jun 22, 2026
pulisher
Jun 20, 2026

Edwards Lifesciences Stocklong-term heart valve strategy in focus - AD HOC NEWS

Jun 20, 2026

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
BSX BSX
$44.81
price down icon 1.08%
$64.68
price down icon 0.32%
$74.06
price up icon 0.67%
PHG PHG
$27.58
price down icon 2.30%
STE STE
$209.49
price down icon 2.74%
大文字化:     |  ボリューム (24 時間):